companies / enveda-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-06 json
| total_raised | 350,000,000350.0M | ○ |
|---|---|---|
| founded | 2019 | |
| hq | Boulder, USA | |
| industry | unknown | |
| stage | series-b+ |
Enveda is a Boulder biotech mining plant chemistry with mass spectrometry and AI to find oral small-molecule drugs. It targets immunology, obesity, and neurosensory indications where natural products historically failed for cost. Pipeline includes ENV-294 in Phase 2a for atopic dermatitis and ENV-308 in Phase 1 for weight maintenance.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2025-09-15 | series-d+ | 150,000,000150.0M | null | ○ |
Cloudflare, WordPress, Google Tag Manager, Fathom, Site Kit 1.179.0, Slick, Popper, Drift, HubSpot, Cloudflare Bot Management, WP Engine, PHP
| fact | status | src |
|---|---|---|
| Series D+, $150.0M | attributed | ○ |
| existence | sourced | WEB |
| description | self-reported | WEB |
| date | fact | change | src |
|---|---|---|---|
| 2026-10-17provenance_existence: self-reported → sourced, WEB 2026-10-17 | provenance_existence | self-reported → sourced | WEB 2026-10-17 |
Records begin 2026-09-24. all_changes